Landmark trials in endocrine adjuvant therapy for breast carcinoma

13Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The review summarizes the outcomes of several landmark trials involving aromatase inhibitors that helped formulate current therapeutic approaches recommended by the American Society of Clinical Oncology for breast carcinoma treatment. © 2006 American Cancer Society.

Cite

CITATION STYLE

APA

Gradishar, W. (2006, March 1). Landmark trials in endocrine adjuvant therapy for breast carcinoma. Cancer. https://doi.org/10.1002/cncr.21707

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free